Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
794.00    4.00 (0.51%)
Bid:
774.00
Ask:
780.00
Spread: 6.00 (0.775%)
Market Cap: £366.00m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Pre-close trading update

1 Dec 2014 07:00

RNS Number : 3904Y
Porvair PLC
01 December 2014
 



For immediate release 1 December 2014

 

 

 

Pre-close trading update

 

Porvair ("Porvair" or "the Group"), the specialist filtration and environmental technologies group, makes the following announcement regarding trading for the year ended 30 November 2014 ahead of its close period.

 

Porvair has continued to trade strongly throughout the year. Both divisions are expected to deliver record results, with revenue for the full year up 24% (28% at constant exchange rates) and earnings marginally ahead of current market expectations.

 

Strong operating cash flow has increased net cash at the year end to around £5m, achieved after capital investments of £5m, mostly spent on expanding manufacturing capacity to meet demand.

 

As anticipated in previous announcements, Group revenue in 2014 received a one-off boost of £20m (2013: £6m) from several large contracts, each of which is proceeding as expected. Profits on these contracts are recognised after making appropriate allowance for the outstanding liabilities, potential risks and warranties. Consequently, we expect further profits to be achieved as milestones are successfully passed over the period to 2017.

 

Revenue in the Microfiltration division was 34% (36% at constant exchange rates) ahead of the prior year. Underlying revenue growth, excluding the impact of the large projects mentioned above, was 9% (11% at constant exchange rates). Aerospace revenue continued to grow steadily and Seal Analytical recorded a record result for the year.

 

Revenue in the Metals Filtration division was 5% (11% at constant exchange rates) ahead of the prior year. Market share gains continued to be made, particularly in iron foundry filtration. The new plant in Wuhan, China, is performing as expected and revenue from aluminium filtration in China was strong.

 

The Group has adopted IAS19 Revised, Employee Benefits, in the year ended 30 November 2014. This increases the defined benefit pension scheme costs charged in the accounts and requires a revision of prior years. Earnings per share for the year ended 30 November 2013, the comparative period, are restated at 12.3 pence compared with the previously reported 12.7 pence.

 

Order books for the start of 2015 are healthy and the Group has a promising pipeline of potential projects.

 

Porvair will announce its preliminary results for the year ended 30 November 2014 on Monday 26 January 2015.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

 

Buchanan Communications

 

0207 466 5000

Charles Ryland / Steph Watson

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration and environmental technology businesses. Its products are used in a range of niche filtration markets, and are derived from its expertise in the design and manufacture of filtration systems using ceramic, metal, plastic and carbon media. Its Seal Analytical business is a market leader in the manufacture of laboratory based water analysis equipment.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDVLFLZFFLFBK
Date   Source Headline
7th Mar 20169:01 amRNSHolding(s) in Company
7th Mar 20169:00 amRNSHolding(s) in Company
1st Feb 201611:38 amRNSDirector/PDMR Shareholding
25th Jan 20167:00 amRNSFull Year Results
7th Dec 20157:00 amRNSPre-close trading update and acquisition
17th Sep 20154:15 pmRNSDirector/PDMR Shareholding
15th Sep 20157:00 amRNSTrading Update
12th Aug 20151:15 pmRNSHolding(s) in Company
12th Aug 20151:11 pmRNSHolding(s) in Company
10th Jul 201512:45 pmRNSDirector/PDMR Shareholding
29th Jun 20157:00 amRNSInterim Results
23rd Jun 20155:00 pmRNSHolding(s) in Company
2nd Jun 20157:00 amRNSTrading Update
29th May 20155:31 pmRNSTotal Voting Rights
30th Apr 20157:02 amRNSDirector declaration
14th Apr 20152:55 pmRNSAGM resolutions
14th Apr 20157:00 amRNSAGM Statement and Trading Update
24th Mar 20152:25 pmRNSPosting of Accounts
11th Mar 20157:00 amRNSHolding(s) in Company
5th Feb 20157:00 amRNSHolding(s) in Company
30th Jan 20154:03 pmRNSEx-Dividend Date
27th Jan 201512:11 pmRNSDirectors' Shareholdings and Issue of Equity
26th Jan 201512:30 pmRNSDirector Declaration
26th Jan 20157:00 amRNSSignificant Contract Wins
26th Jan 20157:00 amRNSFull Year Results
4th Dec 20147:00 amRNSSignificant Contract Win
1st Dec 20147:00 amRNSPre-close trading update
5th Nov 20147:00 amRNSDirector/PDMR Shareholding
16th Sep 20147:00 amRNSInterim Management Statement
23rd Jun 20147:00 amRNSInterim Results
5th Jun 20148:50 amRNSTotal Voting Rights
3rd Jun 20147:00 amRNSTrading Update
23rd Apr 201411:39 amRNSDirector Declaration
8th Apr 20144:20 pmRNSAGM resolutions
8th Apr 20147:00 amRNSAGM Statement and IMS
25th Feb 20147:00 amRNSAppointment of Non-Executive Director
3rd Feb 201410:08 amRNSDirector/PDMR Shareholding
27th Jan 20147:00 amRNSPreliminary Results
16th Jan 20144:07 pmRNSBlocklisting Application
4th Dec 20137:00 amRNSPre-close trading update
29th Nov 20134:02 pmRNSTotal Voting Rights
26th Sep 20137:00 amRNSAcquisition and Licensing agreement
25th Sep 20134:10 pmRNSDirector/PDMR Shareholding
17th Sep 20137:00 amRNSInterim Management Statement
7th Aug 20134:32 pmRNSHolding(s) in Company
6th Aug 20137:00 amRNSContract extension
15th Jul 201311:17 amRNSHolding(s) in Company
9th Jul 20135:13 pmRNSHolding(s) in Company
28th Jun 201312:25 pmRNSHolding(s) in Company
28th Jun 201312:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.